SLSvetlana Vitalievna Lomteva

Svetlana Vitalievna Lomteva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Svetlana Vitalievna Lomteva has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The involvement of polymorphisms in the MALAT1 and NEAT1 lncRNA genes in PCOS etiology

    by Svetlana Vitalievna Lomteva, Karina Yurievna Sagamonova, Ruba Mohamad Ali, Manar Noor Aldeen Ammar, Sofia Valeryevna Yachneva, Anzhela Aslanovna Aleksandrova

    Background: Hormonal imbalance and metabolic inefficiency are hallmarks of the common complicated endocrine condition known as polycystic ovary syndrome (PCOS). Long non-coding RNAs (lncRNAs) have emerged as critical regulators of gene expression and cellular processes in various diseases, including PCOS. This study aims to investigate the relationship between specific polymorphisms in the lncRNA genes MALAT1 (rs3200401) and NEAT1 (rs674485) and the likelihood of developing PCOS. A case-control study was conducted involving PCOS women and control undergoing in vitro fertilization (IVF) at the Center for Human Reproduction and IVF in Rostov-on-Don, Russia. Genotyping was conducted using an allele-specific real-time PCR approach. Results: Our results suggest a possible association between MALAT1 rs3200401 and increased PCOS risk at the allelic level. While the difference observed in the GA genotype of NEAT1 rs674485 did not reach statistical significance and required confirmation in larger cohorts. In addition, deviation from the Hardy–Weinberg equilibrium was observed in control groups, which may reflect sample size limitations or population-specific effects. Bioinformatic analyses indicated that both variants may potentially influence the lncRNA secondary structure and microRNA binding sites; however, these findings are computational predictions and require experimental validation. Conclusion: These findings underscore the potential of MALAT1 and NEAT1 genetic variants as biomarkers and therapeutic targets in PCOS.

  • Open Access

    Роль микроРНК, регулирующих гены окислительного стресса, при синдроме поликистозных яичников

    by Светлана Ломтева, Артур Сагомонов, Евгения Харченко

    Синдром поликистоза яичников (СПЯ) часто сочетается с хроническим окислительным стрессом, нарушающим инсулиновую сигнализацию и оогенез. Цель исследования: Систематизировать микроРНК, непосредственно регулирующие гены окислительного стресса при СПЯ. Методы: Анализ публикаций за последние 25 лет для сопоставление мишеней микроРНК с путями антиоксидантной защиты с использованием баз данных: HMDD, PCOSKB и miRTargetLink 2.0. Результаты: miR-145 подавляет пролиферацию гранулёзных клеток, ингибируя сигнальный путь IRS1/MAPK ERK; miR-16 воздействует на PDCD4 и подавляет апоптоз; miR-323-3p регулирует гены IGF1/PDCD4; miR-324-3p регулирует пролиферацию и апоптоз в гранулезных клетках посредством воздействия на ген WNT2B; miR-222 подавляет экспрессию SOD2; miR-27a участвует в фолликулогенезе, регулирует ген Nrf2; miR-93 подавляет активность антиоксидантного гена NFE2L2 и стимулирует апоптоз; miR-21 участвует в развитии фолликулов и стероидогенезе, усиливакет продукцию активных форм кислорода и подавляет активность SOD2 и SOD3. Заключение: Показано, что miR-145; miR-323-3p; miR-324-3p; miR-146a; miR-93 и miR-21 могут служить диагностическими/прогностическими маркерами и мишенями терапии СПЯ, что в конечном итоге может улучшить фертильность, метаболическое здоровье и качество жизни у женщин с СПЯ.

  • Open Access

    The role of long noncoding RNA H19 in the pathogenesis of polycystic ovary syndrome

    by Svetlana Lomteva

    Polycystic ovary syndrome (PCOS) is a common endocrine disorder accounting for ~70–80% of cases of female annovulatory infertility. Genetic factors, including non-coding RNAs, are involved in the etiology of PCOS. The aim of this paper is to systematize experimental and clinical data on the role of long non-coding RNA H19 in the pathogenesis of PCOS, to consider patterns of dysregulation and impact of H19 on steriogenesis in the blood, follicular fluid, cumulus and granulosa cells; to analyze associations of H19 polymorphisms with the risk of PCOS development; and to assess the potential of H19 as a diagnostic and therapeutic target. The obtained data indicate that H19 is stably dysregulated in the blood, follicular fluid, granulosa/cumulus cells in patients with PCOS. H19 integrates key links of pathogenesis: ovarian function (H19/let 7→AMH axis), inflammation and granulosa cell pyroptosis (H19/miR 29a 3p→NLRP3/HDAC1 axis), cell proliferation (H19/miR 19b→CTGF), steroidogenesis (CYP17A1 and testosterone), and STAT3 signaling. An association of the rs2067051 genetic variant of the H19 gene with the risk of developing PCOS in certain populations has been shown.

  • The role of oxidative stress-related genes in polycystic ovary syndrome: insights into genetic susceptibility and pathogenesis

    by Светлана Витальевна Ломтева

    Oxidative stress is a major factor in the development and progression of polycystic ovary syndrome. It drives metabolic disturbances, systemic inflammation, and ovarian dysfunction. Excessive production of reactive oxygen species, combined with weakened antioxidant defenses, exacerbates insulin resistance, hyperandrogenism, and impaired folliculogenesis. Genetic variations in antioxidant genes further influence this imbalance, shaping individual susceptibility to the syndrome. His review summarizes the role of key antioxidant defense genes, including SOD2, GPX1, GPX4, CAT, and PON1, and examines their associations with polycystic ovary syndrome risk and clinical outcomes. Polymorphism, such as SOD2 rs4880 and GPX4 rs713041 show relatively consistent links with polycystic ovary syndrome, whereas other variants display population-specific effects. Understanding the genetic basis of oxidative stress may advance biomarker discovery and support the development of personalized therapeutic strategies for women with this disease. The development of precision therapy protocols for this syndrome, taking into account genetic testing and lifestyle data, will help improve the reproductive and metabolic health of women with polycystic ovary syndrome.


  • Open Access

    FSHB and FSHR genes variants in combination with hormones levels predict low and high ovarian response to controlled ovarian stimulation: a logistic regressive model

    by Olga V. Lyangasova, Svetlana V. Lomteva, Karina Y. Sagamonova, Elena V. Butenko, Tatiana P. Shkurat

    Background: Predicting the number of follicles obtained after controlled ovarian stimulation (COS) is challenging, especially considering individual variability. Since FSH is a fundamental hormone that controls growing follicle activity, genetic variants are predicted to affect ovarian response to stimulation. The aim of the study: The purpose of this study was to analyze whether FSHB rs10835638 and FSHR rs6166 genetic variants in combination with clinical parameters might be considered as potential precise predictors of ovarian response during COS. Materials and methods: The present study included 144 women from infertile couples who underwent assisted reproductive technologies. Women with reduced FSH and/or AMH serum levels were excluded from the study. Genotyping was carried out applying restriction fragment length polymorphism analysis. Results: Genotypes frequencies for FSHB rs10835638 and FSHR rs6166 were GG (73%), GT (24%), TT (3%) and AA (42%), AG (39%), GG (19%), respectively. FSHR rs6166 GG genotype was shown as associated with higher early follicular phase serum FSH, LH and progesterone levels, compared to AA and AG genotypes. Logistic regressive models that simultaneously use the patient’s genetic and clinical characteristics to calculate the probability of low or high ovarian response have been developed. Conclusion: The present study suggests that rs10835638 and rs6166 genetic variants affect hypothalamic-pituitary–gonadal hormones serum levels, and together may provide an improved model for predicting an ovarian response during COS.


  • Open Access

    Differential expression of CYP19A1 and lncRNA-CTBP1-AS in the granulosa cells of women with polycystic ovary syndrome

    by Ruba M. Ali, Southern Federal University, Svetlana V. Lomteva, Anzhela A. Aleksandrova, Karina Yu. Sagamonova, Artur S. Sagamonov, Manar N.A. Ammar, Tatiana P. Shkurat, Center For Human Reproduction And Ivf, Nauka, et al.

    Background: Hyperandrogenism is the basic indicator of polycystic ovarian syndrome (PCOS) and a ...


  • Effect of polymorphisms CYP17 (rs743572), SOD2 (rs4880) and CAT (rs1001179) on hormonal profile and redox status of blood serum and follicular fluid in patients with polycystic ovary syndrome

    by Ruba Mohamed Ali, Svetlana Vitalievna Lomteva, Anzhela Aslanovna Aleksandrova, Ludmilla Valeryevna Gutnikova, Elena Sergeevna Bugrimova, Karina Yurievna Sagamonova, Manar Noor Aldeen Ammar, Tatiana Pavlovna Shkurat


  • Open Access

    Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?

    by Lomteva S V, Shkurat T P, Bugrimova E S, Zolotykh O S, Alexandrova A A, Karantysh G V

    Polycystic ovary syndrome (PCOS) is the main cause of female infertility. The role of insulin resistance in the development of polycystic ovary is actively discussed here. The study included patients with PCOS without insulin resistance (n = 48) and with insulin resistance (n = 39). The comparison groups were patients with no history of PCOS: a control group without insulin resistance (n = 46) and a group of patients with insulin resistance (n = 45). The following parameters were determined in patients: FSH, LH, TSH, T3f, T4f, PRL, E2, 17-OHd, Pr, AMH, Test total, Testf, DHEAS, DHEASs, SHBG, ACTH, cortisol, IRI, IGF-1, C-peptide, and glucose level. The HOMA-IR index and the LH / FSH ratio and the total / SHBG test were calculated. Correlation analysis was also performed between HOMA IR and indicators of the hormonal profile, IGF-1, and C-peptide.Unidirectional changes in the levels of the following hormones were found in insulin resistance, PCOS and / or insulin resistance relative to control values: estradiol, total testosterone, cortisol, prolactin, AMG, and SHBG. As a result of the correlation analysis, negative relationships were established between the HOMA IR Index and the levels of E2, cortisol and AMH in patients (except for the control group).We assume that the formation of the phenotype of polycystic ovary with a combination of insulin resistance can be formed in patients with insulin resistance as a result of a decrease in the level of estradiol, SHBG and an increase in the content of total testosterone and AMH.